赠卵周期中晚卵泡期孕酮升高是否影响胚胎质量与累积活产率
该回顾性分析纳入2010–2017年397个新鲜赠卵周期,按触发日血清孕酮≤1.5或>1.5 ng/mL分组,比较第3天优质胚胎率与累积活产率。结果显示晚卵泡期孕酮升高不影胚胎质量与累积活产率,多因素回归亦未发现其负向影响。
要点
- 赠卵周期中晚卵泡期孕酮升高不降低第3天优质胚胎率。
- 晚卵泡期孕酮升高不降低赠卵周期的累积活产率。
- 孕酮升高组获卵数及第3天胚胎数更高,但 maturation 与受精率无差异。
核心结论
- 在赠卵周期中,晚卵泡期血清孕酮升高对胚胎质量和累积活产率均无负面影响。
研究设计与样本
- 回顾性分析纳入2010–2017年单中心397个新鲜赠卵周期,供者仅纳入一次且对应单一受者。
- 按触发日血清孕酮≤1.5 ng/mL与>1.5 ng/mL分组,主要终点为第3天优质胚胎率,次要终点为累积活产率(>24周活产)。
主要发现
- 314个周期(79%)孕酮≤1.5 ng/mL,83个周期(20.9%)孕酮>1.5 ng/mL。
- 孕酮升高组获卵数16.6±10.6 vs 11.5±6.9(P<0.001),第3天总胚胎数6.6±5.6 vs 4.15±3.5(P<0.001),优质胚胎数8.7±6.3 vs 6.1±4.4(P<0.001)。
- 两组成熟率、受精率、第3天优质胚胎率(P=0.384)、良好胚胎率(P=0.405)及胚胎利用率(P=0.645)均无显著差异。
- 多因素回归校正孕酮分组、供者年龄、获卵数及优质胚胎率后,晚卵泡期孕酮升高未负向影响优质胚胎率或累积活产率。
临床怎么用
- 赠卵周期中触发日孕酮>1.5 ng/mL不应单独作为取消新鲜胚胎移植或判定胚胎质量下降的依据。
局限性
- 观察性回顾性研究,需前瞻性试验验证。
- 结果仅适用于赠卵周期,不能推广至全部不孕人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does late follicular-phase elevated serum progesterone (LFEP) during ovarian stimulation for oocyte donation have an impact on embryo quality (EQ) and cumulative live birth rate (CLBR)? SUMMARY ANSWER: LFEP does not have an influence on EQ nor CLBR in oocyte donation cycles. WHAT IS KNOWN ALREADY: Ovarian stimulation promotes the production of progesterone (P) which, when elevated during the follicular phase, has been demonstrated to have a deleterious effect in autologous fresh IVF outcomes. While there is robust evidence that this elevation results in impaired endometrial receptivity, the impact on EQ remains a matter of debate. The oocyte donation model is an excellent tool to assess the effects of LFEP on EQ from those on endometrium receptivity separately. Previous studies in oocyte donation cycles investigating the influence of elevated P on pregnancy outcomes in oocyte recipients showed conflicting results. STUDY DESIGN, SIZE, DURATION: This is a retrospective analysis including all GnRH antagonist down-regulated cycles for fresh oocyte donation taking place in a tertiary referral university hospital between 2010 and 2017. A total of 397 fresh donor-recipient cycles were included. Each donor was included only once in the analysis and could be associated to a single recipient. PARTICIPANTS/MATERIALS, SETTING, METHODS: The sample was stratified according to serum P levels of ≤1.5 and >1.5 ng/mL on the day of ovulation triggering. The primary endpoint of the study was the top-quality embryo rate on Day 3, and the secondary outcome measure was CLBR defined as a live-born delivery beyond 24 weeks. MAIN RESULTS AND THE ROLE OF CHANCE: Three hundred ninety-seven fresh oocyte donation cycles were included in the analysis, of which 314 (79%) had a serum P ≤ 1.5 ng/mL and 83 (20.9%) had a serum P > 1.5 ng/mL. The average age of the oocyte donors was 31.4 ± 4.7 and 29.9 ± 4.5 years, respectively, for normal and elevated P (P = 0.017). The mean number of oocytes retrieved was significantly higher in the elevated P group with 16.6 ± 10.6 vs 11.5 ± 6.9 in the P ≤ 1.5 group (P < 0.001).In parallel, the total number of embryos on Day 3, as well as the number of good-quality embryos at this stage, was significantly higher in the elevated P group (6.6 ± 5.6 vs 4.15 ± 3.5 and 8.7 ± 6.3 vs 6.1 ± 4.4; respectively, P < 0.001). However, maturation and fertilization rates did not vary significantly between the two study groups and neither did the top- and good-quality embryo rate and the embryo utilization rate, all evaluated on Day 3 (P = 0.384, P = 0.405 and P = 0.645, respectively). A multivariable regression analysis accounting for P groups, age of the donor, number of retrieved oocytes and top-quality embryo rate as potential confounders showed that LFEP negatively influenced neither the top-quality embryo rate nor the CLBR. LIMITATIONS, REASONS FOR CAUTION: This is an observational study based on a retrospective data analysis. Better extrapolation of the results could be validated by performing a prospective trial. Furthermore, this study was focused on oocyte donation cycles and hence the results cannot be generalized to the entire infertile population. WIDER IMPLICATIONS OF THE FINDINGS: This is the first study providing evidence that LFEP does not influence CLBR and is adding strong evidence to the existing literature that LFEP does not harm EQ in oocyte donation programs. STUDY FUNDING/COMPETING INTERESTS: Not applicable.
引用
- Racca A, De Munck N, Santos-Ribeiro S, et al. Do we need to measure progesterone in oocyte donation cycles? A retrospective analysis evaluating cumulative live birth rates and embryo quality. Hum Reprod. 2020. PMID: 31953546. doi:10.1093/humrep/dez238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。